About Fez family zinc finger protein 1
Fez family zinc finger protein 1 (FEZF1) is a protein
from Homo sapiens identified by UniProt accession
A0PJY2, 475 residues long.
MolForge cross-references it against 0 known binders and
95 disease associations.
Target properties
| Protein name | Fez family zinc finger protein 1 |
| UniProt accession | A0PJY2 |
| Gene | FEZF1 |
| Organism | Homo sapiens |
| Length | 475 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (95)
Diseases linked to this target (Open Targets).
- Kallmann syndrome · score 0.52
- hypogonadotropic hypogonadism · score 0.51
- diet measurement · score 0.42
- age at first sexual intercourse measurement · score 0.42
- chronotype measurement · score 0.30
- lean body mass · score 0.19
- genetic disorder · score 0.19
- fat body mass · score 0.18
- body mass index · score 0.17
- body height · score 0.16
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-A0PJY2-F1 | alphafold | PREDICTED | 56.00 | — |
Amino-acid sequence (475 residues)
MDSSCHNATT KMLATAPARG NMMSTSKPLA FSIERIMART PEPKALPVPH FLQGALPKGE PKHSLHLNSS IPCMIPFVPV AYDTSPKAGV TGSEPRKASL EAPAAPAAVP SAPAFSCSDL LNCALSLKGD LARDALPLQQ YKLVRPRVVN HSSFHAMGAL CYLNRGDGPC HPAAGVNIHP VASYFLSSPL HPQPKTYLAE RNKLVVPAVE KYPSGVAFKD LSQAQLQHYM KESAQLLSEK IAFKTSDFSR GSPNAKPKVF TCEVCGKVFN AHYNLTRHMP VHTGARPFVC KVCGKGFRQA STLCRHKIIH TQEKPHKCNQ CGKAFNRSST LNTHTRIHAG YKPFVCEFCG KGFHQKGNYK NHKLTHSGEK QFKCNICNKA FHQVYNLTFH MHTHNDKKPF TCPTCGKGFC RNFDLKKHVR KLHDSSLGLA RTPAGEPGTE PPPPLPQQPP MTLPPLQPPL PTPGPLQPGL HQGHQ
Explore Fez family zinc finger protein 1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets